525 related articles for article (PubMed ID: 31023261)
1. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
[TBL] [Abstract][Full Text] [Related]
2. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
3. Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer.
Ramlov A; Kroon PS; Jürgenliemk-Schulz IM; De Leeuw AA; Gormsen LC; Fokdal LU; Tanderup K; Lindegaard JC
Acta Oncol; 2015; 54(9):1567-73. PubMed ID: 26271799
[TBL] [Abstract][Full Text] [Related]
4. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.
Rash DL; Lee YC; Kashefi A; Durbin-Johnson B; Mathai M; Valicenti R; Mayadev JS
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):317-22. PubMed ID: 23906933
[TBL] [Abstract][Full Text] [Related]
5. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
6. Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
Bacorro W; Dumas I; Escande A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C
Gynecol Oncol; 2018 Mar; 148(3):461-467. PubMed ID: 29325690
[TBL] [Abstract][Full Text] [Related]
7. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
[TBL] [Abstract][Full Text] [Related]
8. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
Choi KH; Kim JY; Lee DS; Lee YH; Lee SW; Sung S; Park HH; Yoon SC; Hur SY; Park JS; Kim YS
Medicine (Baltimore); 2018 Apr; 97(16):e0517. PubMed ID: 29668638
[TBL] [Abstract][Full Text] [Related]
10. Intensity modulated radiation therapy boost in locally-advanced cervical cancer in the absence of brachytherapy.
Lazzari R; Riva G; Augugliaro M; Vavassori A; Dicuonzo S; Cattani F; Comi S; Colombo N; Jereczek-Fossa BA
Int J Gynecol Cancer; 2020 May; 30(5):607-612. PubMed ID: 32188626
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Lin AJ; Ma S; Markovina S; Schwarz J; Mutch DG; Powell MA; Grigsby PW
Gynecol Oncol; 2019 Jun; 153(3):530-534. PubMed ID: 30905434
[TBL] [Abstract][Full Text] [Related]
12. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
13. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract][Full Text] [Related]
14. High dose simultaneous integrated boost for node positive cervical cancer.
Jayatilakebanda I; Tsang YM; Hoskin P
Radiat Oncol; 2021 May; 16(1):92. PubMed ID: 34001158
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET/CT guided external beam radiotherapy volumes in inoperable uterine cervical cancer.
Adam JA; Arkies H; Hinnen K; Stalpers LJ; van Waesberghe JH; Stoker J; van Os R; Laan JJ; Mom CH; van Eck-Smit BL
Q J Nucl Med Mol Imaging; 2018 Dec; 62(4):420-428. PubMed ID: 29869485
[TBL] [Abstract][Full Text] [Related]
16. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
[TBL] [Abstract][Full Text] [Related]
17. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
[TBL] [Abstract][Full Text] [Related]
18. Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.
Kim H; Park W; Cho WK
J Radiat Res; 2020 May; 61(3):479-486. PubMed ID: 32211854
[TBL] [Abstract][Full Text] [Related]
19. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study.
Sethi R; Mayadev J; Sethi S; Rash D; Chen LM; Brooks R; Ueda S; Hsu IC
Pract Radiat Oncol; 2019 Mar; 9(2):e180-e186. PubMed ID: 30342181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
